Università degli Studi dell'Insubria Insubria Space
 

InsubriaSPACE - Thesis PhD Repository >
Insubria Thesis Repository >
01 - Tesi di dottorato >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10277/826

Authors: Antunes Coelho, Marisa Alexandra
Internal Tutor: COSENTINO, MARCO
Co-tutor: PEREIRA TEIXEIRA RIBEIRO, LAURA VIRGÍNIA
Title: Beta-blockers in oncology setting: paving the way for lung cancer
Abstract: With the growing amount of studies revealing the involvement of β-adrenoceptors (β-AR) in the progression of multiple types of tumours, the hypothesis that β-blockers could be potential candidates for drug repurposing in oncology setting has gaining momentum. In lung cancer, it could be particularly meaningful considering the disappointing results of the current therapeutic approaches. The compilation of studies disclosed in this thesis intended to investigate the presence β-AR in non-small cell lung cancer (NSCLC) as well as discuss the potential for repurposing β-blockers as a new therapeutic approach for lung cancer. The studies included in this thesis comprise a narrative review, a clinicopathologic study, an in vitro study, and a meta-analysis exploring the effect of β-blockers on overall survival of lung cancer patients and a letter to the editor. The obtained results suggest that β01 and β2-AR are differently expressed in the histologic subtypes, adenocarcinoma (ADC) and squamous cell carcinoma (SCC). We found that β1-AR expression is present at low levels in both SCC and ADC whereas β2-AR is higher expressed on both histologic subtypes but clearly higher expressed in ADC. The meta-analysis performed, including 7448 patients, showed that lung cancer patients using β-blockers had no increased overall survival when compared to non-users. Altogether, this work increased the knowledge on the expression pattern of β-AR on NSCLC. Despite the lack of a positive effect of β-blockers on lung cancer overall survival obtained in the meta-analysis, this study should prompt the attention of the scientific community to the fact that there is still a huge margin for improving the concept of β-blockers repurposing in cancer.
Keywords: β-adrenoceptors; β-blockers, lung cancer, drug repurposing
Subject MIUR : BIO/14 FARMACOLOGIA
Issue Date: 2018
Language: eng
Doctoral course: Medicina clinica e sperimentale e Medical Humanities
Academic cycle: 30
Publisher: Università degli Studi dell'Insubria
Other university: University of Porto - Portugal - PhD course Experimental and clinical pharmacology and toxicology
Citation: Antunes Coelho, M.A.Beta-blockers in oncology setting: paving the way for lung cancer (Doctoral Thesis, Università degli Studi dell'Insubria, 2018).

Files in This Item:

File Description SizeFormatVisibility
PhD_Thesis_AntunesCoelho_MarisaAlexandra_completa.pdftesto completo tesi41,65 MBAdobe PDFavailable from: 17/12/2020 View/Open

This item is licensed under a Creative Commons License
Creative Commons


Items in InsubriaSPACE are protected by copyright, with all rights reserved, unless otherwise indicated.


Share this record
Del.icio.us

Citeulike

Connotea

Facebook

Stumble it!

reddit


 

  ICT Support, development & maintenance are provided by the AePIC team @ CILEA. Powered on DSpace Software.  Feedback